One preliminary experience on humans was conducted by Vrieze et al. in 2012: The authors demonstrated that the transfer of intestinal microbiota from lean donors could increase insulin sensitivity in individuals with metabolic syndrome [37]. The gene discussed is INS; the disease is metabolic syndrome.